TGFB1 and systemic lupus erythematosus: Our previous study demonstrated that increased miR-663 in SLE BM-MSCs contributed to lupus development through inducing imbalance of T follicular helper and T regulatory cells by targeting TGF-β1 and knock down of miR-663 in BM-MSCs may improve the efficacy of MSC-based cytotherapy (15).